CXBS (Corix Bioscience) OCF Margin %: 0.00% (As of Sep. 2017)


What is Corix Bioscience OCF Margin %?

Corix Bioscience CXBS -99.00% OCF Margin % is 0.00% as of Sep. 2017.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Corix Bioscience's Cash Flow from Operations for the three months ended in Sep. 2017 was $-1.72 Mil. Corix Bioscience's Revenue for the three months ended in Sep. 2017 was $0.00 Mil. Therefore, Corix Bioscience's OCF Margin % for the quarter that ended in Sep. 2017 was 0.00%.

As of today, Corix Bioscience's current OCF Yield % is -19,400.00%.

The historical rank and industry rank for Corix Bioscience's OCF Margin % or its related term are showing as below:

CXBS' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -451.3

CXBS's OCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 9.985 vs CXBS: -451.30

Corix Bioscience OCF Margin % Related Terms

Corix Bioscience OCF Margin % Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience OCF Margin % Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -266.43

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CXBS vs BKIT, YBAO, HSTI: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corix Bioscience OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's OCF Margin % falls into.


Corix Bioscience OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Corix Bioscience's OCF Margin for the fiscal year that ended in Dec. 2016 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=-1.849/0.694
=-266.43 %

Corix Bioscience's OCF Margin for the quarter that ended in Sep. 2017 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2017 )/Revenue (Q: Sep. 2017 )
=-1.722/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Corix Bioscience (CXBS) has a OCF Margin % of 0.00% as of Sep. 2017. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Corix Bioscience and its competitors.
Is Corix Bioscience's OCF Margin % too high?
Corix Bioscience's current OCF Margin % is 0.00%.
How does Corix Bioscience's OCF Margin % compare to BKIT and YBAO?
Corix Bioscience's OCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Corix Bioscience and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corix Bioscience's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current OCF Margin % is 0.00% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.